LeadIQ logo
Learn more at LeadIQ.com

Insights

New CEO Evozyne recently appointed Marc Yoskowitz as the CEO, signaling potential changes in leadership direction and a chance for new partnerships or collaborations.

Generative AI Model Evozyne is developing a generative AI model in collaboration with NVIDIA, presenting an opportunity to leverage cutting-edge technology for enhancing product development and attracting tech-savvy clients.

Series B Financing With a recent $81M funding in Series B, Evozyne has financial resources to expand operations, invest in research, and potentially seek new clients or strategic acquisitions.

Protein Therapeutics Evozyne specializes in designing novel protein therapeutics, offering a unique value proposition that can attract pharmaceutical companies looking for innovative solutions for unaddressed patient needs.

Market Trends In an industry where AI-driven solutions and biotech advancements are gaining traction, Evozyne's focus on AI models and high-performing proteins aligns well with current market trends, presenting opportunities for partnerships with forward-thinking organizations.

Similar companies to Evozyne

Evozyne Tech Stack

Evozyne uses 8 technology products and services including GitHub, NoSQL, MySQL, and more. Explore Evozyne's tech stack below.

  • GitHub
    Communication And Collaboration
  • NoSQL
    Database
  • MySQL
    Database
  • Asana
    Issue Trackers
  • React
    Javascript Frameworks
  • JavaScript
    Programming Languages
  • Haskell
    Programming Languages
  • Linux
    Programming Languages

Evozyne's Email Address Formats

Evozyne uses at least 1 format(s):
Evozyne Email FormatsExamplePercentage
First.Last@evozyne.comJohn.Doe@evozyne.com
50%
First.Last@evozyne.comJohn.Doe@evozyne.com
50%

Frequently Asked Questions

Where is Evozyne's headquarters located?

Minus sign iconPlus sign icon
Evozyne's main headquarters is located at Chicago, IL US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Evozyne's official website and social media links?

Minus sign iconPlus sign icon
Evozyne's official website is evozyne.com and has social profiles on LinkedIn.

How much revenue does Evozyne generate?

Minus sign iconPlus sign icon
As of October 2024, Evozyne's annual revenue reached $15M.

What is Evozyne's SIC code NAICS code?

Minus sign iconPlus sign icon
Evozyne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evozyne have currently?

Minus sign iconPlus sign icon
As of October 2024, Evozyne has approximately 59 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Drug Discovery Officer: U. H.Vice President Operations: J. A.Head Of Computation: A. F.. Explore Evozyne's employee directory with LeadIQ.

What industry does Evozyne belong to?

Minus sign iconPlus sign icon
Evozyne operates in the Biotechnology Research industry.

What technology does Evozyne use?

Minus sign iconPlus sign icon
Evozyne's tech stack includes GitHubNoSQLMySQLAsanaReactJavaScriptHaskellLinux.

What is Evozyne's email format?

Minus sign iconPlus sign icon
Evozyne's email format typically follows the pattern of . Find more Evozyne email formats with LeadIQ.

How much funding has Evozyne raised to date?

Minus sign iconPlus sign icon
As of October 2024, Evozyne has raised $81M in funding. The last funding round occurred on Sep 27, 2023 for $81M.

When was Evozyne founded?

Minus sign iconPlus sign icon
Evozyne was founded in 2020.
Evozyne

Evozyne

Biotechnology ResearchIllinois, United States51-200 Employees

Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. 

Section iconCompany Overview

Headquarters
Chicago, IL US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconFunding & Financials

  • $81M

    Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.

  • $10M$50M

    Evozyne's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $81M

    Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.

  • $10M$50M

    Evozyne's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.